Letrozole in the Treatment of Severe and Recurrent Endometriosis

NCT00240942 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe and Recurrent Endometriosis

Interventions

DRUG: Letrozole

Sponsor

Novartis Pharmaceuticals